a.hartmann
TL2 Moderator · Seville
Contributes reviews on supplier material. Based in Seville.
Joined 25 August 2025 · last posted 20h
88 posts, newest first. Showing up to 150.
-
Shakes versus food: a pragmatic assessment Replied, post #27 · Nutrition & Training › Protein & intake · 27 Jul 2026 · 26 likes Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what you did and when. The single most useful thing in your own…
-
Reading order for a first week here, and what to skip until later — what changed since Replied, post #85 · Start Here › Welcome · 26 Jul 2026 · 21 likes There is no stupid-questions rule and no penalty for asking badly. The response to a poorly framed question is a request for clarification, not rudeness. That is a…
-
How to ask about something you suspect is a bad idea — a second dataset Started this topic · Start Here › How to Ask · 15 Jul 2026 · 0 likes How to ask about something you suspect is a bad idea — a second dataset — that is the question, and I have not found it answered plainly anywhere I have looked.…
-
Coming back to: Delayed gastric emptying and oral medication absorption: which drugs… Replied, post #24 · Practice › Interactions · 14 Jul 2026 · 0 likes Picking up post #21: that is the part I would want checked first. Insulin interaction: semaglutide and tirzepatide are not contraindicated with insulin but the…
-
What a certificate commits its issuer to — one year on Replied, post #103 · Analytics › COA interpretation · 5 Jul 2026 · 5 likes Coming back to post #101, because the follow-up matters more than the original answer. Two things before anyone answers the substance. First, the context in the first…
-
[2026 update] Interpreting a result that disagrees with the supplier's certificate Replied, post #38 · Sourcing › Independent verification · 24 Jun 2026 · 0 likes Interpreting a result: a purity figure is one measurement on one vial on one day. Agreement across two services is much stronger. A single high number does not…
-
Endotoxin and why it is a separate question from purity — what changed since Replied, post #55 · Analytics › Impurities & related substances · 23 Jun 2026 · 0 likes Incomplete deprotection: mass higher by the protecting group mass. Usually markedly later eluting. A synthesis artifact from incomplete removal of protecting groups.
-
Prescription portability between countries Replied, post #72 · Access › International · 21 Jun 2026 · 0 likes Licensed prescribing: where a compound is approved, prescribing is restricted to licensed prescribers. Where it is not approved, the legality of possession and use is…
-
[2026 update] Area percent versus weight percent: the confusion that causes most arguments Replied, post #59 · Analytics › HPLC & UHPLC · 17 Jun 2026 · 12 likes Before anything else: what was the gradient, and at what wavelength? Area percent at different wavelengths is not the same number even on the same sample because…
-
Type 2 diabetes and the largest part of the evidence base — does this still hold? Replied, post #15 · Clinical › Comorbidities · 17 Jun 2026 · 0 likes Multiple comorbidities: a person with diabetes, kidney disease, and cardiovascular disease is outside the studied populations in most trials. Extrapolating to that…
-
An appeal that succeeded, with the letter structure — the long version Replied, post #93 · Access › Insurance & coverage · 13 Jun 2026 · 23 likes post #92 answers the question as asked. The question underneath it is different. Coverage for weight management versus diabetes: many formularies cover these compounds…
-
Injecting into an area that has become firm: why not to Replied, post #34 · Practice › Administration · 8 Jun 2026 · 0 likes Air bubbles in a subcutaneous injection: the honest risk assessment is low. Tiny air bubbles in subcutaneous tissue do not behave like an air embolism in a blood…
-
Reading a trial's population section before its results Replied, post #75 · Evidence › Trials · 1 Jun 2026 · 28 likes Coming back to post #73, because the follow-up matters more than the original answer. Having read the exchange above, I think I was wrong earlier in this topic and I…
-
Follow-up: A parcel that arrived warm: a decision process, not a verdict Replied, post #48 · Practice › Storage & stability · 29 May 2026 · 30 likes Freeze-thaw: some peptide solutions tolerate freezing poorly because ice crystals damage protein structure. Whether your specific solution tolerates it depends on the…
-
[2026 update] Storing lyophilised material long term: what governs the shelf life Replied, post #124 · Practice › Storage & stability · 28 May 2026 · 19 likes Temperature excursions: if a vial sat at room temperature for a time, the question is whether the excursion was long enough to cause damage. Hours at room temperature…
-
Revisiting: Primary endpoint hierarchies and why order matters Started this topic · Evidence › Trials · 3 May 2026 · 43 likes Posting this under the heading it deserves: Revisiting: Primary endpoint hierarchies and why order matters Everything below is what sits behind that. Comparing…
-
Semaglutide and gastric emptying — the mechanism behind most of the side-effect profile Replied, post #14 · Compounds › Semaglutide · 2 May 2026 · 24 likes post #13 is right about the mechanism and I think understates the practical bit. I disagree with the reply above, and I think the disagreement is substantive rather…
-
Why oral semaglutide needs an absorption enhancer at all — one year on Replied, post #11 · Compounds › Oral incretins · 17 Apr 2026 · 9 likes The SOUL trial: cardiovascular outcomes trial for oral semaglutide in people with type 2 diabetes and cardiovascular disease or chronic kidney disease. It demonstrates…
-
Subgroup analyses: pre-specified versus discovered — a second dataset Replied, post #46 · Evidence › Trials · 15 Apr 2026 · 0 likes Coming back to post #44, because the follow-up matters more than the original answer. Intent-to-treat versus per-protocol: ITT includes everyone assigned regardless of…
-
[2026 update] 0.3 mL versus 0.5 mL versus 1 mL barrels: resolution matters Replied, post #24 · Devices › Syringes & needles · 12 Apr 2026 · 0 likes Dead volume: residual liquid in the hub and needle after withdrawal. Typical residual is 0.01 to 0.02 mL for an insulin syringe with a fixed needle. Accounting for it…
-
The "under review" status pill and when a moderator applies it Replied, post #59 · Evidence › Preprints · 7 Apr 2026 · 16 likes I read post #57 twice before replying, because I had assumed the opposite. Server repositories: medRxiv for medicine, bioRxiv for biology. Preprints on these servers…
-
Stepping down deliberately, and how to do it without losing progress Replied, post #86 · Practice › Dosing & titration · 4 Apr 2026 · 8 likes post #85 answers the question as asked. The question underneath it is different. Stepping down deliberately: the withdrawal trials show that stopping is followed by…
-
Journal club: is percentage weight change the right endpoint? Replied, post #32 · Evidence › Journal club · 2 Apr 2026 · 0 likes SURMOUNT-1 (N Engl J Med 2022): Tirzepatide obesity trial. The largest mean weight reduction for a pharmacological intervention at publication. Read the categorical…
-
Managing an unplanned gap in supply Replied, post #75 · Access › Shortages · 27 Mar 2026 · 0 likes post #74 is right about the mechanism and I think understates the practical bit. Compounding during shortages: some jurisdictions allow pharmacy compounding when a…
-
Choosing which test to pay for, given a fixed budget Replied, post #28 · Sourcing › Independent verification · 17 Mar 2026 · 3 likes Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what you did and when. The single most useful thing in your own…
-
Measurement error in home scales, with a worked standard deviation Replied, post #25 · Research Methods › Statistics · 16 Mar 2026 · 15 likes Effect sizes: the magnitude of a difference, not just whether it is statistically significant. A difference that is significant (p
-
Second pass at: What "verified" means on our vendor pages, stated narrowly Replied, post #78 · Sourcing › Vendor reports · 7 Mar 2026 · 0 likes Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what you did and when. The single most useful thing in your own…
-
A history of disordered eating: proceeding carefully Replied, post #75 · Wellbeing › Mental health · 27 Jan 2026 · 0 likes Identity and self-image: for some people, weight and body size are central to identity. Large change to body size can affect identity. This is not pathological; it is…
-
The headache that turns out to be dehydration Replied, post #146 · Nutrition & Training › Hydration & electrolytes · 20 Jan 2026 · 5 likes Worth separating two things that post #142 runs together. The very ordinary causes of week-two malaise: inadequate hydration, low sodium intake, too-rapid calorie…
-
Rotating between abdomen, thigh and upper arm: absorption differences — one year on Replied, post #10 · Practice › Administration · 17 Jan 2026 · 1 like Angle of injection: 90 degrees into pinched tissue ensures subcutaneous placement. It is not always necessary and shallower angles can work, but 90 degrees into a small…
-
Request: a diff view for wiki revisions — the long version Replied, post #99 · Meta › Feature requests · 14 Jan 2026 · 0 likes Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what you did and when. The single most useful thing in your own…
-
Anxiety in the first weeks: drug, situation, or both — what changed since Replied, post #71 · Wellbeing › Mental health · 2 Jan 2026 · 5 likes Body image and weight loss: large weight loss changes a person's relationship with their body in ways that can be psychologically complex. Some of that is positive;…
-
Reading SURMOUNT-1 without the press release Replied, post #122 · Compounds › Tirzepatide · 31 Dec 2025 · 27 likes Titration schedules for tirzepatide have more dose steps than semaglutide partly because the compound is more potent and partly because the clinical programme used a…
-
Why an oral GLP-1 agonist is a formulation achievement more than a chemistry one Replied, post #104 · Compounds › Oral incretins · 22 Dec 2025 · 27 likes Oral versus injectable exposure: comparing a 14 mg oral dose with a 0.5 mg injectable dose is comparing apples to a different fruit. The oral bioavailability is low…
-
Freeze-thaw and why one cycle is not the same as five Replied, post #23 · Practice › Storage & stability · 15 Nov 2025 · 0 likes Picking up post #20: that is the part I would want checked first. Dating prepared solutions: write the date reconstitution on the vial in permanent marker. If you later…
-
Where to report an adverse event officially, by region — a second dataset Replied, post #114 · Safety › Adverse events · 10 Nov 2025 · 0 likes Medullary thyroid carcinoma is the reason these compounds are contraindicated in people with personal or family history of MTC or multiple endocrine neoplasia type 2.…
-
High-resolution MS on aggregates and what it can see Replied, post #114 · Analytics › Mass spectrometry · 7 Nov 2025 · 11 likes Worth separating two things that post #110 runs together. What mass accuracy establishes: the measured mass is consistent with a specific composition. What it does not…
-
Coming back to: Resolution and tailing factor: real acceptance criteria Replied, post #109 · Analytics › HPLC & UHPLC · 16 Oct 2025 · 33 likes On post #105 — agreed on the reasoning, with one qualification. Method validation is the demonstration that a method can separate the compound from its degradation…
-
What the GIP component of tirzepatide is thought to contribute, and how confident we can… Replied, post #52 · Compounds › Tirzepatide · 10 Oct 2025 · 3 likes post #51 answers the question as asked. The question underneath it is different. For anyone arriving from a search: the marked solution above is the direct answer, and…
-
Power cut for eleven hours: how I assessed it afterwards Replied, post #86 · Practice › Storage & stability · 7 Oct 2025 · 17 likes Worth separating two things that post #82 runs together. Two things before anyone answers the substance. First, the context in the first post is clear and specific.…
-
Citing a preprint in a maintained document: our rule and its reasoning — does this still… Replied, post #101 · Evidence › Preprints · 3 Oct 2025 · 0 likes Picking up post #98: that is the part I would want checked first. Do not build anything on a preprint that you would mind rebuilding: if the preprint later changes…
-
Reading a supplier's product description as a marketing document Replied, post #78 · Compounds › Other compounds · 2 Oct 2025 · 17 likes Reading a supplier's product description as a marketing document: that is exactly what it is. The hyperbole, the mechanism written as fact, the theoretical benefits…
-
Second pass at: Programming during a large energy deficit Replied, post #19 · Nutrition & Training › Resistance training · 26 Sep 2025 · 0 likes Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly rather than quietly editing. The correction was fair and I had…
-
Payment method and the leverage it gives you, ranked Replied, post #75 · Sourcing › Payments · 25 Sep 2025 · 0 likes Worth separating two things that post #71 runs together. Currency conversion: payment in your local currency often involves a conversion fee. Paying in the supplier's…
-
Where the integrator drew the baseline, and how much it moved the number Replied, post #9 · Analytics › HPLC & UHPLC · 21 Sep 2025 · 0 likes Area percent is not mass percent. It is a proportion of absorbance, weighted by each species' extinction coefficient. For closely related impurities the approximation…
-
Coming back to: Where the integrator drew the baseline, and how much it moved the number Started this topic · Analytics › HPLC & UHPLC · 12 Sep 2025 · 0 likes On the subject in the title: Where the integrator drew the baseline, and how much it moved the number Working notes rather than a conclusion. Posting the method first,…
-
About the Site feedback category Replied, post #4 · Meta › Site feedback · 10 Sep 2025 · 6 likes Suggestion for the wiki post above: it would be worth linking the two or three most-referenced topics in this category directly, since new members reliably ask for…
-
Adolescents: a distinct evidence base — one year on Replied, post #14 · Clinical › Special populations · 5 Sep 2025 · 20 likes Medullary thyroid carcinoma history: an absolute contraindication because of the preclinical findings in rodent toxicology. The history (personal or family, especially…
-
Tirzepatide molecular mass and the charge states you would expect on ESI Replied, post #9 · Compounds › Tirzepatide · 24 Aug 2025 · 5 likes Storage and stability: published data on licensed tirzepatide formulations exists and is worth reading directly rather than through summarised claims. Reconstituted…
-
Fatigue in the first month: how much is the drug and how much is intake — what changed… Replied, post #32 · Practice › Side effects · 13 Aug 2025 · 4 likes I read post #30 twice before replying, because I had assumed the opposite. Having read the exchange above, I think I was wrong earlier in this topic and I want to say…
-
Travel coolers and how long they really hold Replied, post #80 · Devices › Cold chain · 8 Aug 2025 · 24 likes Assessing an excursion: if a package sat at room temperature for a time, visual inspection (cloudiness, discoloration, particles) can alert you to problems. Not visible…
-
Reading a combination trial: attributing effect to components Replied, post #2 · Compounds › Cagrilintide & amylin analogues · 8 Aug 2025 · 33 likes Nausea profile of amylin analogues: the historical agent pramlintide required multiple daily doses and had a difficult tolerability profile. A weekly formulation is a…
-
Promotion criteria, and the one that stops most nominations — the long version Replied, post #37 · Documentation › Doc review · 7 Aug 2025 · 22 likes On post #33 — agreed on the reasoning, with one qualification. Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what…
-
What a documentation review can and cannot tell you Replied, post #53 · Sourcing › Independent verification · 30 Jul 2025 · 0 likes How to submit a sample: contact the service directly. They will provide instructions on vial type, quantity, labelling, shipping. Following their instructions exactly…
-
Trial registration and comparing the protocol with the paper Replied, post #20 · Evidence › Trials · 8 Jul 2025 · 12 likes Coming back to post #18, because the follow-up matters more than the original answer. Practical note that does not fit anywhere else. Whatever you conclude from this…
-
Foaming during reconstitution and whether it matters Replied, post #18 · Practice › Reconstitution · 3 Jul 2025 · 26 likes Choosing a concentration on purpose rather than by accident: starting with "I want to draw 0.5 mL per dose" and working backward to the required concentration is more…
-
Coming back to: Official shortage notices and what they authorise Replied, post #23 · Access › Shortages · 6 Jun 2025 · 23 likes Supply interruptions: official shortage notices are published by regulatory agencies. That is the correct primary source rather than pharmacy rumors or forum discussion.
-
Pre-registering a personal experiment, seriously Replied, post #74 · Research Methods › N-of-1 designs · 1 Jun 2025 · 3 likes When to run an n-of-1: this design works when you want to know whether a treatment works for you, not whether it works in general. For that purpose, it is efficient.
-
Half-life, steady state, and accumulation worked through Replied, post #27 · Pharmacology › Pharmacokinetics · 26 May 2025 · 9 likes Renal clearance: these compounds are cleared partly via the kidney. In severe renal impairment, clearance is slowed and accumulation risk is higher. Dose adjustments…
-
A 5 mg vial and a 0.25 mg dose: the arithmetic in full — the long version Replied, post #117 · Practice › Reconstitution · 26 May 2025 · 0 likes Thank you for the correction. I have edited my earlier post with a note rather than silently, so the thread still makes sense to read. The error was mine and it was the…
-
Asking about a compound your prescriber has not heard of Replied, post #47 · Clinical › Prescriber conversations · 24 May 2025 · 0 likes Worth separating two things that post #43 runs together. Understanding stopping rules: what would prompt stopping the compound? Adverse effect, lack of benefit after a…
-
DXA precision and the least significant change for lean mass — the long version Replied, post #49 · Outcomes › Body composition · 16 May 2025 · 0 likes For anyone arriving from a search: the marked solution above is the direct answer, and the replies underneath it add the caveats that make it safe to use.
-
[2026 update] What the GIP component of tirzepatide is thought to contribute, and how… Replied, post #55 · Compounds › Tirzepatide · 16 May 2025 · 0 likes This follows post #52 rather than contradicting it. Thank you for the correction. I have edited my earlier post with a note rather than silently, so the thread still…
-
Journal club: SURMOUNT-1, read without the press release Replied, post #113 · Evidence › Journal club · 9 May 2025 · 10 likes SOUL (N Engl J Med 2025): Oral semaglutide cardiovascular outcomes. Extends the cardiovascular evidence to the oral formulation. Note that oral bioavailability is lower…
-
Journal club: STEP 1 and the treatment-policy estimand — does this still hold? Replied, post #66 · Evidence › Journal club · 20 Apr 2025 · 31 likes STEP 1 (N Engl J Med 2021): The pivotal obesity trial for semaglutide and the reference point for most subsequent comparison. Mean weight reduction was substantially…
-
Reading order for a first week here, and what to skip until later Replied, post #86 · Start Here › Welcome · 16 Apr 2025 · 16 likes I disagree with the reply above, and I think the disagreement is substantive rather than terminological. The distinction being drawn does not survive when you look at…
-
Adjudicated events and why the definition matters — the long version Replied, post #84 · Evidence › Trials · 6 Apr 2025 · 0 likes Risk of bias: structured appraisal of internal validity. Key things to assess: randomisation method (was it truly random or could someone predict the next assignment),…
-
What SELECT changed about how semaglutide is discussed, and what it did not Replied, post #60 · Compounds › Semaglutide · 1 Apr 2025 · 11 likes I disagree with the reply above, and I think the disagreement is substantive rather than terminological. The distinction being drawn does not survive when you look at…
-
[2026 update] US compounding rules and how they changed Replied, post #3 · Regional › North America · 8 Mar 2025 · 28 likes I read the opening post twice before replying, because I had assumed the opposite. Two things before anyone answers the substance. First, the context in the first post…
-
Distinguishing a deletion sequence by mass alone Replied, post #98 · Analytics › Mass spectrometry · 17 Feb 2025 · 3 likes Charge states observed: for semaglutide (4113.6 Da) the doubly charged ion appears at m/z ≈ 2057, triply charged at ≈ 1371, quadruply at ≈ 1029. Those are the positions…
-
Random versus fixed effects: choosing rather than defaulting — a second dataset Replied, post #105 · Evidence › Meta-analyses · 13 Feb 2025 · 4 likes Sensitivity analysis: the authors re-run the meta-analysis excluding studies one at a time, or by quality, to see whether the pooled estimate changes. Robust results…
-
Isotonicity and what happens when you get it wrong Replied, post #29 · Pharmacology › Formulation chemistry · 15 Jan 2025 · 18 likes Lyophilisation and reconstitution: the powder is stable for extended periods if kept cool and dry. Once reconstituted, stability decreases because the dissolved peptide…
-
Books and papers worth reading that are not about this at all Replied, post #13 · Lounge › Off topic · 6 Jan 2025 · 9 likes Newer drugs and mechanisms: when a new drug launches or a new mechanism is discovered, the Lounge is a place to discuss the news and speculate before hard data exists.
-
Sample size intuition for a personal experiment Replied, post #4 · Research Methods › Statistics · 30 Dec 2024 · 19 likes On the opening post — agreed on the reasoning, with one qualification. Relative risk and odds ratios: both compare the rate in one group to the rate in another.…
-
Coming back to: When to suspect the method rather than the sample Replied, post #136 · Analytics › Method validation · 26 Dec 2024 · 0 likes Thank you for the correction. I have edited my earlier post with a note rather than silently, so the thread still makes sense to read. The error was mine and it was the…
-
Persistent vomiting and the threshold for seeking help — one year on Replied, post #21 · Safety › Adverse events · 20 Dec 2024 · 0 likes On post #17 — agreed on the reasoning, with one qualification. Severe gastrointestinal events: persistent vomiting, abdominal pain out of proportion, or signs of bowel…
-
Building a sensible monitoring schedule with your prescriber Replied, post #41 · Clinical › Bloodwork · 20 Dec 2024 · 13 likes Fasting state: some lab tests require fasting; others do not. Lipids on a fasting draw differ from lipids on a fed draw. Always note whether the test was fasting when…
-
[2026 update] New subcategory: rationale and scope Replied, post #22 · Meta › Announcements · 25 Nov 2024 · 8 likes Notifications: watching this subcategory means you receive notifications when announcements are posted. Useful if you want to stay current.
-
Reading a preclinical wound-healing model and its relevance to a human tendon Replied, post #82 · Compounds › Repair & healing peptides · 18 Nov 2024 · 19 likes BPC-157: the preclinical literature is extensive, mostly from a small number of research groups, and reports effects across a wide range of injury models. The breadth…
-
Research-use-only labelling: what it means and what it does not — the long version Replied, post #12 · Sourcing › Regulatory · 16 Oct 2024 · 2 likes Picking up post #9: that is the part I would want checked first. For anyone arriving from a search: the marked solution above is the direct answer, and the replies…
-
Irish differences from the UK position Replied, post #31 · Regional › UK & Ireland · 10 Oct 2024 · 10 likes On post #27 — agreed on the reasoning, with one qualification. Compounding pharmacies: UK allows compounding under specific conditions when a licensed product is…
-
Progressive overload when the scale is falling — one year on Replied, post #76 · Nutrition & Training › Resistance training · 21 Sep 2024 · 0 likes Programming while losing weight quickly: realistic expectations are crucial. Strength often stays surprisingly stable; power output might decline slightly. Expecting…
-
Circumference measurements as a poor man's composition estimate Replied, post #104 · Outcomes › Body composition · 28 Aug 2024 · 3 likes Visceral fat: DXA does not distinguish visceral (organ-associated) fat from subcutaneous fat. That distinction might matter but requires different imaging to measure.
-
Second pass at: A field-by-field walk through a certificate of analysis Replied, post #38 · Analytics › COA interpretation · 27 Aug 2024 · 0 likes Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly rather than quietly editing. The correction was fair and I had…
-
Reporting a discrepancy without making an allegation Replied, post #32 · Sourcing › Vendor reports · 18 Aug 2024 · 31 likes Picking up post #29: that is the part I would want checked first. I disagree with the reply above, and I think the disagreement is substantive rather than…
-
Coming back to: Purity assay versus content assay: two different numbers Replied, post #60 · Analytics › COA interpretation · 13 Aug 2024 · 15 likes Sterility testing is separate: chromatographic purity, mass spectrometry, and endotoxin testing all say nothing about whether a solution is sterile. If sterility…
-
Guidelines revision: what changed and why Replied, post #3 · Meta › Announcements · 24 Jul 2024 · 1 like I read the opening post twice before replying, because I had assumed the opposite. Feedback to announcements: if you have feedback on an announced change (not a…
-
Cold packs, phase-change material, and what survives ten days Replied, post #19 · Sourcing › Logistics · 16 Jun 2024 · 16 likes Picking up post #16: that is the part I would want checked first. Documentation after arrival: photograph the parcel and its contents on arrival. If something later…